Journal Details

Therapeutics NOW is a high-quality, single-anonymized peer-reviewed journal dedicated to the publication of cutting-edge research in the field of innovative medical treatments and technologies. The journal serves as a platform for scientists, clinicians, and industry experts to share groundbreaking advancements in areas such as gene therapy, immunotherapy, drug discovery, and personalized medicine. Therapeutics NOW spans the scope of research from bench to bedside for results aimed at the development of next-generation therapeutics.

Therapeutics NOW is an international, peer-reviewed Gold Open Access journal where reviewers remain anonymous to authors. It is dedicated to addressing urgent global challenges in therapeutic development and accessibility. It aligns with the United Nations Sustainable Development Goal 3: Good Health and Well-being, addressing the critical need for innovative and affordable treatments.

Each article includes a Research Significance Highlight to showcase its contribution to therapeutic progress.

Why publish with us?

• Open Access Journal
  All articles are freely accessible worldwide, ensuring broad dissemination and engagement across academia, industry, and healthcare sectors.
• Interdisciplinary Scope
  We welcome contributions from across therapeutic sciences including chemistry, biology, engineering, clinical research, and policy—reflecting the complexity and diversity of modern healthcare challenges.
• Translational Impact
  Our focus on bridging basic science and clinical application ensures that published work contributes meaningfully to patient care and therapeutic innovation.
• Aligned with UN Sustainable Development Goal 3
  We support research that advances good health and well-being, contributing to global efforts to improve healthcare equity and outcomes.
• Fast Decisions with Select Crowd Review
  Our innovative peer review model combines expert evaluation with rapid turnaround, helping authors receive constructive feedback and editorial decisions quickly.
• Unique Article Types
  We offer formats tailored to real-world relevance, including Policy & Impact Briefs and Industrial Case Studies, enabling authors to share insights beyond traditional research articles.
• Research Significance Highlight
  Each published article features a concise summary of its significance, helping readers quickly grasp its relevance and potential impact.

Journal scope

Therapeutics NOW welcomes a broad spectrum of research and encourages interdisciplinary collaboration across chemistry, biology, bioengineering, and clinical sciences. It covers therapeutic advances from laboratory research to clinical application, emphasizing translational impact and real-world relevance. It addresses mainly but not exclusively the following areas of evidence-based research:

• Applied Computational Biology
  Including structure-activity relationship (SAR) modeling, structure-based design, and AI-driven prediction tools for therapeutic development.
• Drug Discovery & Development
  Covering research on the design and optimization of bioactive small molecules and chemically derived therapeutics, including studies on drug discovery, metabolism, toxicity, regulatory sciences, affinity-inducing agents, and chemical proteomics. The section emphasizes advances in medicinal chemistry and pharmacological profiling that drive the translation of new chemical entities into viable drug candidates.
• Theragnostics & Targeted Therapies
  Studies involving biomarkers, nanomedicine, drug delivery systems, and precision medicine approaches.
• Biopharmaceuticals
  Covering research on biologically derived and next-generation therapeutics including monoclonal antibodies, peptides, vaccines, bioconjugates, and Advanced Therapy Medicinal Products (ATMPs) such as cell and gene therapies. The section emphasizes innovations in biotechnology, manufacturing, delivery, and regulatory considerations that enable the development of complex biologics and novel therapeutic modalities.
• Disease-Focused Therapeutics
  Applied research targeting tropical, infectious, and common diseases, with emphasis on molecular design and treatment strategies.
• Cancer Biology & Immunotherapy
  Mechanistic insights and therapeutic innovations in oncology and immune-based treatments.
• Preventive Medicine
  Including research on the development of vaccines for infectious diseases, oncology, and inflammatory conditions, as well as the advancement of novel adjuvants and delivery systems.
• Diagnostics & Instrumentation
  Development of novel diagnostic procedures and therapeutic-oriented instruments and methods.
• Synthetic Biology & Biomedical Engineering
  Applications of synthetic biology in drug development, tissue engineering, and therapeutic systems.
• Chemical Biology and Molecular Biology                                   
  Covering studies on the development of chemical probes to investigate cellular mechanisms and toxicology as they relate to drug action, this section emphasizes target validation in support of therapeutic efficacy and drug discovery.

Out of the scope of Therapeutics NOW will be: 

• Basic chemistry and biology with no proven therapeutic application
• Pure synthetic chemical routes to new potential drug candidates without demonstration of therapeutic application
• Disease pharmacology without involvement of any therapeutic intervention 
• Homeopathic or alternative traditional medicines 
• Surgical procedures